PFE/MYL—Viatris* merger now expected to close in 2H20 (rather than 1H20): https://www.businesswire.com/news/home/20200326005190/en/Mylan-Pfizer-Provide-Update-Proposed-Combination-Mylan *MYL + PFE’s Upjohn unit for off-patent drugs.